Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Journal of Translational Medicine|January 9, 2009
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinomaHoward L Kaufman, Bret Taback, William Sherman, et al.Annals of Surgery|December 10, 2015
Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance)Judy C Boughey, Karla V Ballman, Huong T Le-Petross, et al.Annals of Surgical Oncology|May 5, 2019
A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim AnalysisSheila H Ridner, Mary S Dietrich, Michael S Cowher, et al.Lymphatic Research and Biology|August 22, 2018
A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months PostoperativelySheila H Ridner, Mary S Dietrich, Kandace Spotanski, et al.Annals of Surgical Oncology|July 24, 2015
Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of LymphedemaSheldon Feldman, Hannah Bansil, Jeffrey Ascherman, et al.Oncoimmunology|October 15, 2021
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic MelanomaMerve Hasanov, Denái R Milton, William H Sharfman, et al.Annals of Surgery|February 10, 2015
Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)Judy C Boughey, Vera J Suman, Elizabeth A Mittendorf, et al.Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|August 28, 2023
Presenting for Duty: Lessons From A Specialty Surgery Division at the Pandemic EpicenterRoshni Rao, Luona Sun, Charise Acevedo, et al.Journal for Immunotherapy of Cancer|July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanomaJoseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.Cancer|July 7, 2022
Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with interventionLouise A Koelmeyer, Katrina Gaitatzis, Mary S Dietrich, et al.Pageof 7